No. 2.

Содержание/Table of contents

1. Comparative Efficacy and Tolerability of Immediate-Release Clozapine (AZALEPTIN®) and Extended Release Clozapine (Azaleptin® Retard) in Patients with Schizophrenia Resistant to Antipsychotic Therapy

   A.E. Aliforenko, V.A. Khazanov, Valentin Vladimirovich Larchenko, V.V. Bykov, P.D. Yudina, A.A. Demyanova

   PDF (Русский)

2. Risk of Rhabdomyolysis during Therapy with Atypical Antipsychotics: Evaluation of Safety Signals

   V.Yu. Skryabin, D.A. Sychev, S.I. Sokolova, A.S. Serova, M.V. Zuzenkov

   PDF (Русский)

3. Ventricular Repolarization Index in Patients with Schizophrenia during Antipsychotic Therapy

   S.A. Galkin, E.G. Kornetova, D.A. Petkun, A.N. Kornetov

   PDF (Русский)

4. Sexual Dysfunction in Patients with Schizophrenia during Antipsychotic Therapy

   K.K. Konyushenko, N.N. Petrova, А.А. Avramov, S.Yu. Ilyasov

   PDF (Русский)

5. Use of Original and Generic Fluvoxamine in Clinical Psychiatric and Neurological Practice for the Treatment of Depression (Physician Survey Results)

   S.N. Mosolov, А.S. Avedisova, E.S. Nemkova

   PDF (Русский) PDF

1. The place of Phenazepam in Modern Clinical Practice: Effective and Safe Therapy for Anxiety Disorders and Beyond

   D.V. Romanov, A.M. Sheyanov

   PDF (Русский)

2. Current Understanding of the Pathogenesis and Treatment of Generalized Anxiety Disorder

   V.I. Frolova, D.K. Egiazaryan

   PDF (Русский)

1. Lamotrigine and Folic Acid in Bipolar Disorder — An Incompatible Combination? Clinical Cases

   T.V. Zhilyaeva, T.V. Bogdanova

   PDF (Русский)